HEATHER FAITH: Open Payments
NPI 1831976547 · WASHINGTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$271 in 14 payments from 8 companies in 2025. Trend: 2023 $54 · 2024 $91 · 2025 $271
Food & beverage: $271
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $95 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Novo Nordisk Inc | 2 | $36 |
| ABIOMED | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $17 |
| Amgen Inc. | 1 | $16 |
| Tris Pharma Inc | 1 | $16 |
Products named: VRAYLAR, AIRSUPRA, Auvelity, Ozempic, MOUNJARO, Wegovy, OTEZLA, Dyanavel XR.
Industry payments across IN — which companies pay providers there.
